Emerging evidence suggests that a plethora of inflammatory mediators can trigger and modulate cardiomyocyte apoptosis, with blockade of IL-1 and IL-17 signaling pathways shown to ameliorate systolic function during MI (Lin et al., 2022; Zhao et al., 2020). The gene discussed is IL17A; the disease is myocardial infarction.